EDIT vs EMR · rev $32.3M vs P/E 34, rev $4.86B
Editas Medicine Inc (EDIT) versus Emerson Electric Company (EMR) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
EDIT currently screens at market cap $375.2M. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Not investment advice. Open the EDIT and EMR stock pages for the full models.
Not investment advice.